Welcome to our dedicated page for Kaya Hldgs news (Ticker: KAYS), a resource for investors and traders seeking the latest updates and insights on Kaya Hldgs stock.
Kaya Holdings, Inc. (OTCQB: KAYS) generates news across several emerging sectors, including psilocybin treatment services, medical and recreational cannabis, and, more recently, digital assets and cryptocurrency. Its announcements provide insight into how the company is developing The Sacred Mushroom™ psilocybin treatment center in Portland, Oregon, managing cannabis-related brands and licenses, and pursuing a Digital Assets Treasury (DAT) strategy through a planned cryptocurrency subsidiary.
News items for KAYS often highlight regulatory milestones and operational updates at The Sacred Mushroom, such as the award of a psilocybin service center license from the Oregon Health Authority, the start of appointment scheduling, the grand opening of the facility, and the introduction of programs like the "Synergy by Design" journey customization framework. Releases also cover educational initiatives, including e-books on psilocybin and commentary on topics such as the potential use of psilocybin in mental health applications.
On the corporate side, Kaya Holdings’ news includes engagements with advisory firms like Greentree Financial Group and Conduit Advisors to support the development of a cryptocurrency operating subsidiary and implementation of its digital assets treasury strategy. Related updates may describe planned joint ventures with cryptocurrency foundations and steps the company is taking to restructure its balance sheet in connection with this strategy.
Investors and observers following KAYS news can expect coverage of licensing developments, facility launches, program rollouts at The Sacred Mushroom, cannabis licensing and branding updates, and strategic moves in digital assets. The news feed provides a way to track how the company’s psilocybin, cannabis and cryptocurrency initiatives evolve under the regulatory and market conditions it describes in its public statements.
Kaya Holdings (OTCQB:KAYS) announced progress toward forming a cryptocurrency operating subsidiary and pursuing a Digital Asset Treasury Company (DATCO) strategy.
The company said its representatives are in discussions with crypto foundations and potential partners, exploring joint-venture candidates among the top ~200 cryptocurrencies, with a preference for Solana, Ethereum, or Polygon networks.
KAYS disclosed agreements to convert over 90% of existing debt into equity to clean up the balance sheet and said it may pursue an eventual uplisting to Nasdaq. The company is also engaging contacts in Grand Cayman to support planned crypto operations.
Kaya Holdings (OTCQB:KAYS) has engaged Greentree Financial Group and Conduit Advisors to develop a new cryptocurrency subsidiary and implement a Digital Assets Treasury (DAT) strategy. The company plans to explore various cryptocurrency initiatives, including setting up licensed custody and trading services in the United States and Grand Cayman.
KAYS aims to leverage its public company status and connections to Grand Cayman, which has emerged as a Cryptocurrency and Digital Assets Financial Center with specific legislation like the Virtual Asset Service Providers Act. The success of this initiative depends on factors including debt restructuring, digital asset acquisition, and securing adequate financing.
Kaya Holdings (OTCQB:KAYS) has announced the launch of 'Synergy by Design' at The Sacred Mushroom™ (TSM), their 11,000 sq. ft. psilocybin treatment center in Portland, Oregon. This new program allows participants to customize their psychedelic journey experience through personalized settings and activities.
The program enables guests to select their preferred environment, including space options (quiet nook, indoor garden, private room), customizable sound elements (live musicians, playlists, nature sounds), and aromatic preferences (essential oils, herbal infusions). Additionally, participants can engage in various activities such as creative expression through art, music, and crafting, as well as mind-body practices like yoga and meditation.
According to KAYS CEO Craig Frank, this initiative leverages the facility's extensive space to create an ideal psilocybin treatment setting, positioning The Sacred Mushroom™ as a pioneer in the $82.47 billion mental healthcare sector.
Kaya Holdings (OTCQB:KAYS) and The Sacred Mushroom™ announce their first Open House event on December 27, 2024, from 5:00 PM to 8:00 PM at their Portland psilocybin treatment center. The event will showcase private treatment rooms, an indoor garden, and various therapeutic activities. The company is also launching a new series called 'Community, Culture, and a Touch of Psilocybin', featuring group sessions focused on low-dose psilocybin experiences combined with artistic appreciation.
The facility has released a free e-book titled 'Is Psilocybin Right for You?' covering various topics including therapeutic benefits, dosing, risks, and applications for conditions such as PTSD, depression, anxiety, and addiction. Attendees will have the opportunity to reserve spots for upcoming sessions at special introductory rates.
The Sacred Mushroom™ (TSM), operated by Kaya Holdings, announced the release of its first e-book, "Is Psilocybin Right for You?". This e-book is part of a planned series aimed at educating the public on the therapeutic benefits of psilocybin for mental health and personal growth. Topics covered include the history of psilocybin, its effects on the brain, and its potential benefits for conditions such as PTSD, depression, anxiety, and more. The e-book is accessible online or can be downloaded for offline reading. TSM, a licensed psilocybin treatment center in Portland, Oregon, offers a curated environment for transformative psychedelic experiences. CEO Craig Frank emphasized the importance of providing information to help individuals make informed decisions about psilocybin treatments. For more details or to book an appointment, visit the TSM website.
Kaya Holdings, Inc. (OTCQB:KAYS) criticizes the FDA's rejection of MDMA therapy for PTSD and proposes psilocybin as an alternative treatment. KAYS operates The Sacred Mushroom™, an 11,000 sq. ft. legally licensed psilocybin treatment center in Portland, Oregon. CEO Craig Frank invites researchers and individuals to consider psilocybin treatment at their facility. Emerging research suggests psilocybin's potential in treating PTSD, with studies showing reduced symptoms after just one or two sessions. Compared to MDMA, psilocybin offers longer sessions, milder side effects, and a preferred safety profile regarding abuse potential and dependency risk. The company emphasizes that psilocybin is not federally legal in the US and advises consulting a physician before making changes to prescription drug treatments.
Kaya Holdings (OTCQB:KAYS) announced the grand opening of its licensed psilocybin treatment center, The Sacred Mushroom (TSM), in Portland, Oregon, on July 5, 2024. The center will begin administering psilocybin treatments to eligible guests, offering an alternative pathway to better health for individuals suffering from PTSD, depression, OCD, anxiety, addictions, eating disorders, and other treatment-resistant mental health disorders. KAYS CEO Craig Frank will be the first to undergo the treatment. The facility aims to provide a premium legal psilocybin experience. For appointments or information, visit The Sacred Mushroom temporary web page or email info@tsmpdx.com.
KAYS encourages stockholders to update their contact information for future updates.
Kaya Holdings, Inc. (OTCQB:KAYS) announced that its subsidiary, Fifth Dimension Therapeutics, has started accepting appointments at The Sacred Mushroom (TSM) Psilocybin Treatment Center in Portland, Oregon. The center provides customized treatments for mental health issues such as PTSD, anxiety, trauma, and addictions. TSM offers proprietary 'Synergy by Design' experiences and group sessions. KAYS CEO Craig Frank emphasized the transformative potential of psilocybin. Recent studies support its effectiveness in treating mental health conditions. The U.S. behavioral health market is projected to exceed $136 billion by 2032. KAYS aims to establish itself in the psychedelic medicine field through its treatment centers.
Kaya Holdings, Inc. (KAYS) has been awarded a license to operate a Psilocybin Service Center in Oregon, becoming the first state in the US to allow Psilocybin administration in a legal setting. Through its subsidiary Fifth Dimension Therapeutics, KAYS will launch The Sacred Mushroom, a psychedelic treatment facility offering innovative experiences. The facility is set to open within the next thirty days in downtown Portland, covering 11,000 square feet. Psilocybin, a compound in magic mushrooms, has shown promise in treating various mental health conditions. KAYS aims to be a leader in psychedelic care delivery, offering a unique guest experience. The US behavioral health market is growing, creating opportunities for companies like KAYS to provide alternative therapies.
Summary not available.